High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccinationCOVID-19 예방 접종이 시작되기 전에 카자흐스탄 카라간다에서 높은 SARS-CoV-2 혈청 유병률Article Published on 2022-07-272022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% CI Administered Antibody-mediated immunity appear Asia asymptomatic subjects capture Clinical characteristics Cohort collected Continuous correlated COVID-19 COVID-19 transmission COVID-19 vaccination death demographic and clinical characteristics detect detectable effort IgA IgG Immunity Infection Kazakhstan mitigate nasopharyngeal swabs National pandemic participant PCR-negative performed positive Prevalence provide public health Questionnaires recruited reported respiratory Respiratory illness RT-qPCR SARS-CoV-2 SARS-CoV-2 seroprevalence serological assays serological surveillance Serologically Seropositivity subject subset Swab tested the antibodies thresholds titre vaccination Virus neutralization were used [DOI] 10.1371/journal.pone.0272008 PMC 바로가기 [Article Type] Article
Etramp5 as a useful serological marker in children to assess the immediate effects of mass drug campaigns for malariaEtramp5는 말라리아를 위한 대규모 약물 캠페인의 즉각적인 효과를 평가하기 위한 유용한 혈청학적 마커로서 어린이에게 사용됩니다.Article Published on 2022-07-262024-08-01 Journal: BMC Infectious Diseases [Category] 말라리아, [키워드] cohort study Evaluation Haiti impact assessment malaria Mass drug administration serology Seropositivity [DOI] 10.1186/s12879-022-07616-8 PMC 바로가기
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS증례 보고서: 코로나19 관련 GBS 이전의 Parainfectious COVID-19 관련 GBS에 따른 Guillain-Barré 증후군의 코로나19 이후 백신 재발Case Reports Published on 2022-07-182022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 유전자 메커니즘, 진단, [키워드] Admission antecedent antibodies antibody Autoimmune Autoimmune diseases autonomic Case report causal link cerebrospinal fluid Combination complete recovery Course COVID-19 COVID-19 pneumonia COVID-19 symptoms COVID-19 vaccine cranial cranial nerves Diagnosis Diplopia disease dysfunction facial first dose Future ganglioside ganglioside antibodies. Guillain-barrè syndrome Guillain–Barrè syndrome ICU IgM immunoglobulins Intravenous immunoglobulin IVIG mechanisms molecular mimicry Neurological disorder observation occurred Patient Pfizer Pfizer/BioNTech Pneumonia recurrence reported SARS-CoV-2 seropositive Seropositivity syndrome therapy unique Vaccinations Vaccine Viral Viral illness viral illnesses weakness [DOI] 10.3389/fimmu.2022.894872 PMC 바로가기 [Article Type] Case Reports
Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study온타리오주의 남아시아 지역 사회에서 SARS-CoV-2 감염에 대한 혈청 양성 및 위험 인자: 전향적 코호트 연구의 횡단면 분석Article Published on 2022-07-052022-09-12 Journal: CMAJ open [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% confidence interval age age and sex antibody Baseline assessment Care Characteristics collected Community conducted COVID-19 COVID-19 pandemic cross-sectional analysis demographic demographic characteristics disease Dried blood spots employment enrolled Essential workers estimate Evidence Factor geographic location Greater Toronto Area GTA Health health information help individual information insight media pandemic participant Population prospective cohort study public health questionnaire reported risk risk factor Risk perception SARS-COV-2 infection Seropositivity South Asian was determined [DOI] 10.9778/cmajo.20220031 PMC 바로가기 [Article Type] Article
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients신장 이식 수혜자에서 세 번째 mRNA SARS-CoV-2 백신 접종 후 B.1.617.2(델타) 및 B.1.1.529(오미크론) 변이체에 대한 중화 항체 반응Observational Study Published on 2022-07-012022-09-11 Journal: American journal of transplantation : official jou [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, 치료기술, [키워드] addition Anti-RBD antibodies anti-receptor-binding domain antibody antibody response against B.1.1.529 B.1.617.2 clinical decision-making Clinical research COVID-19 vaccination cross-neutralization detectable dose healthy control healthy controls IgG immune immune modulation Immunosuppression kidney kidney transplant recipient kidney transplant recipients Kidney transplantation mRNA mRNA vaccine Nephrology neutralization neutralization titer neutralization titers Neutralizing Neutralizing antibodies neutralizing antibody Observational cohort study organ organ transplantation patients Practice reduced SARS-CoV-2 SARS-CoV-2 vaccine sera Seroconversion Seropositivity significantly significantly lower solid organ solid organ transplantation the SARS-CoV-2 Vaccine vaccine dose variant variants of concern wild-type [DOI] 10.1111/ajt.17054 PMC 바로가기 [Article Type] Observational Study
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine ResponseCOVID-19 백신의 4차 접종은 최적의 백신 반응을 보이지 않는 고형 장기 이식 수혜자들 사이에서 오미크론 변이체의 중화를 유도하지 않습니다Article Published on 2022-07-012022-09-11 Journal: Transplantation [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome angiotensin angiotensin-converting enzyme 2 anti-receptor-binding domain Anti-spike anti-spike antibody anti-Spike IgG Antibody Units binding antibody units booster vaccinations change Cohort coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine Delta delta variant domain dose ELISA full-length spike protein Health Organization healthy controls high risk Humoral response humoral responses IgG immune evasion Immunoglobulin increase Infection interquartile range Intervention Live virus median multiplex neutralization neutralizing capacity omicron Omicron variant Protective recipient respiratory response Seropositivity significantly increased significantly lower Solid solid organ solid organ transplant Spike proteins surrogate the vaccine Transplant Vaccination strategy Vaccine vaccine dose vaccine strain variant VoC VOCs was measured Wilcoxon signed-rank test World Health Organization [DOI] 10.1097/TP.0000000000004140 PMC 바로가기 [Article Type] Article
SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort임신 중 SARS-CoV-2 및 관련 결과: 진행중인 예상 코호트의 결과Article Published on 2022-07-012022-09-12 Journal: Paediatric and perinatal epidemiology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% confidence interval acute respiratory syndrome adjusted Admission age Analysis antibody black blood sample BMI Care caused children Cohort conducted coronavirus covariate COVID-19 COVID-19 pandemic Effect eligible enzyme-linked immunosorbent examined expand Generation Health Hispanic Hospital stay IgG IgG antibody Impact individual individuals Infection intensive care medical records Modification Mount Sinai Nasopharyngeal swab Neonatal Neonatal outcomes New York City occurred outcome outcomes participant positive Pregnancy pregnancy outcomes pregnant prenatal Preterm birth prospective cohort prospective cohort study receiving Regression model Result RT-PCR RT-PCR testing SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RT-PCR SARS-CoV-2 seroprevalence selected Seroepidemiologic studies serological test seronegative Seropositivity stratified System tested was performed [DOI] 10.1111/ppe.12812 PMC 바로가기 [Article Type] Article
Low prevalence of community-acquired influenza coinfections among COVID-19 patients in Al-Madinah, Saudi Arabia: A retrospective cohort studyResearch article Published on 2022-07-012022-10-05 Journal: Journal of infection and public health [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute infection Antibody test Care circulating Coinfection Community Community-acquired respiratory infections conducted Confirmed COVID-19 infection COVID-19 pandemic COVID-19 patient COVID-19 patients early phase Effect Epidemics Factor highlight hospital hospitalized patient IgM Immunoglobulin Infection Influenza influenza A influenza B investigated knowledge management Mild MOST occurred other respiratory virus pandemic pandemic disease Pandemics Parainfluenza-2 Patient patients Prevalence Prognosis reported respiratory infection respiratory virus Result retrospective cohort study SARS CoV-2 SARS-CoV-2 Saudi Arabia Seropositivity serum sample virus viruses [DOI] 10.1016/j.jiph.2022.06.001 [Article Type] Research article
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study항체 결핍증이 있는 개인의 SARS-CoV-2 백신 반응: COV-AD 연구 결과Article Published on 2022-07-012022-09-12 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Antibiotic prophylaxis antibody Antibody Response assays AstraZeneca Breakthrough infection cellular response clearance Cohort controls COVID-19 CVID deficiency determine dose Efficacy ELISA Evidence finding General population healthy control IgG immune response immunoglobulin replacement therapy Inborn error inborn errors of immunity individual Infection interferon gamma less magnitude morbidity and mortality nasopharyngeal swabs neutralisation neutralising no difference occurred participant Patient PCR PCR positive Pfizer/BioNTech post vaccination Prevent Primary Immunodeficiency receiving recipient recruited recurrent infection reduced remained reported respond response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination SARS-CoV-2 vaccine secondary secondary antibody secondary immunodeficiency seropositive Seropositivity significantly T cell response the antibody response vaccination Vaccine Vaccines [DOI] 10.1007/s10875-022-01231-7 PMC 바로가기 [Article Type] Article
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma요로상피 및 신세포암 환자에서 SARS-CoV-2 BNT162b2 백신에 대한 혈청학적 반응에 대한 활성 항암 요법의 효과Article Published on 2022-07-012022-09-12 Journal: International journal of urology : official journa [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome adverse events Antibody Response Antibody titer anticancer blood sample BNT162b2 BNT162b2 vaccine Cell control group coronavirus defined dose Effect evaluate evaluated exhibited Factor group groups healthy control Immunoglobulin Logistic regression analysis metastatic disease mRNA mRNA vaccine not significantly different Older age Patient patients renal renal cell carcinoma SARS-CoV-2 SARS-CoV-2 BNT162b2 Serologic response seropositive Seropositivity significantly spike receptor-binding domain steroid treatment the patient therapy Treatment university urothelial carcinoma. vaccination Vaccine [DOI] 10.1111/iju.14882 PMC 바로가기 [Article Type] Article